Immunological Reactions by T Cell and Regulation of Crucial Genes in Treated Celiac Disease Patients

Overview

Journal Gastroenterol Hepatol Bed Bench

Specialty Gastroenterology

Date 2020 Apr 21

PMID 32308937

Citations 8

Authors

Mohammad Rostami-Nejad

Zahra Razzaghi

Somayeh Esmaeili

Sina Rezaei-Tavirani

Alireza Akbarzadeh Baghban

Reza Vafaee

Affiliations

Soon will be listed here.

Abstract

Aim: To assess the immunological reactions and gene expression level in the celiac disease (CD) patients under a gluten-free diet (GFD).

Background: CD is an autoimmune disorder in genetic susceptible individuals and lifelong gluten free diet is the effective treatment method. It seems that treated patients will experience a normal life style though there are documents about some potential damages.

Methods: Gene expression profiles of treated CD patients and healthy samples were obtained from Gene Expression Omnibus (GEO) and compared to find the differentially expressed genes (DEGs). The identified DEGs were introduced in the network and gene ontology (GO) analysis.

Results: Ten differentially expressed genes (DEGs) including CCR2, IRF4, FASLG, CCR4, ICOS, TNFSF18, BACH2, LTF, PRM1, and PRM2 were investigated via network analysis. Seven clusters of biological processes (BP) were determined as the affected BP. PThe finding led to introduction of CCR2, IRF4, FASLG, CCR4, and ICOS as the potential immunological markers that are still active despite GFD in the treated CD patients.

Conclusion: The results of this study indicated that the immune system is already active in treated CD patients despite GFD treatment and exposure to gluten causes potential immunological reactions in these patients.

Citing Articles

From an understanding of etiopathogenesis to novel therapies-what is new in the treatment of celiac disease?.

Skoracka K, Hryhorowicz S, Tovoli F, Raiteri A, Rychter A, Slomski R Front Pharmacol. 2024; 15:1378172.

PMID: 38698821 PMC: 11063403. DOI: 10.3389/fphar.2024.1378172.

Metabolomics and lipidomics signature in celiac disease: a narrative review.

Rostami-Nejad M, Asri N, Bakhtiari S, Khalkhal E, Maleki S, Rezaei-Tavirani M Clin Exp Med. 2024; 24(1):34.

PMID: 38340186 PMC: 10858823. DOI: 10.1007/s10238-024-01295-2.

Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances.

Ivanova M, Bottiglieri L, Sajjadi E, Venetis K, Fusco N Genes (Basel). 2023; 14(2).

PMID: 36833303 PMC: 9956047. DOI: 10.3390/genes14020376.

The role of mir-197-3p in regulating the tight junction permeability of celiac disease patients under gluten free diet.

Asri N, Fallah S, Rostami-Nejad M, Fallah Z, Khanlari-Kochaksaraei M, Jafari-Marandi S Mol Biol Rep. 2022; 50(3):2007-2014.

PMID: 36536183 DOI: 10.1007/s11033-022-08147-w.

Reduced frequency of circulating regulatory T cells and their related immunosuppressive mediators in treated celiac patients.

Asri N, Rostami-Nejad M, Nikzamir A, Aghamohamadi E, Asadzadeh-Aghdaei H, Zali M Mol Biol Rep. 2022; 49(9):8527-8535.

PMID: 35723802 DOI: 10.1007/s11033-022-07674-w.

References

Romaldini C, Barbieri D, Okay T, Raiz Jr R, Cancado E . Serum soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha levels in children with celiac disease: response to treatment. J Pediatr Gastroenterol Nutr. 2002; 35(4):513-7. DOI: 10.1097/00005176-200210000-00010. View

Fasano A, Catassi C . Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001; 120(3):636-51. DOI: 10.1053/gast.2001.22123. View

Tack G, Verbeek W, Schreurs M, Mulder C . The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol. 2010; 7(4):204-13. DOI: 10.1038/nrgastro.2010.23. View

Joseph S, Barai R, Bhujbalrao R, Idicula-Thomas S . PCOSKB: A KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome. Nucleic Acids Res. 2015; 44(D1):D1032-5. PMC: 4702829. DOI: 10.1093/nar/gkv1146. View

Kemppainen T, Kroger H, Janatuinen E, Arnala I, Kosma V, Pikkarainen P . Osteoporosis in adult patients with celiac disease. Bone. 1999; 24(3):249-55. DOI: 10.1016/s8756-3282(98)00178-1. View

Rostami-Nejad M, Vafaee R, Ehsani-Ardakani M, Aghamohammadi N, Keramatinia A, Abdi S . The Screening of Critical Related Genes in Celiac Disease Based on Intraepithelial Lymphocytes Investigation: A Bioinformatics Analysis. Galen Med J. 2021; 8:e1407. PMC: 8343984. DOI: 10.31661/gmj.v8i0.1407. View

Rezaei-Tavirani M, Rezaei Tavirani M, Zamanian Azodi M, Farshi H, Razzaghi M . Evaluation of Skin Response After Erbium:Yttrium- Aluminum-Garnet Laser Irradiation: A Network Analysis Approach. J Lasers Med Sci. 2019; 10(3):194-199. PMC: 6817805. DOI: 10.15171/jlms.2019.31. View

Lagreid A, Hvidsten T, Midelfart H, Komorowski J, Sandvik A . Predicting gene ontology biological process from temporal gene expression patterns. Genome Res. 2003; 13(5):965-79. PMC: 430886. DOI: 10.1101/gr.1144503. View

Van Auken K, Jaffery J, Chan J, Muller H, Sternberg P . Semi-automated curation of protein subcellular localization: a text mining-based approach to Gene Ontology (GO) Cellular Component curation. BMC Bioinformatics. 2009; 10:228. PMC: 2719631. DOI: 10.1186/1471-2105-10-228. View

10.

Zamanian Azodi M, Peyvandi H, Rostami-Nejad M, Safaei A, Rostami K, Vafaee R . Protein-protein interaction network of celiac disease. Gastroenterol Hepatol Bed Bench. 2016; 9(4):268-277. PMC: 5118851. View

11.

Fina D, Sarra M, Caruso R, Del Vecchio Blanco G, Pallone F, MacDonald T . Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut. 2007; 57(7):887-92. DOI: 10.1136/gut.2007.129882. View

12.

Rezaei-Tavirani M, Rezaei-Tavirani S, Ahmadi N, Naderi N, Abdi S . Pancreatic adenocarcinoma protein-protein interaction network analysis. Gastroenterol Hepatol Bed Bench. 2018; 10(Suppl1):S85-S92. PMC: 5838186. View

13.

Gujral N, Freeman H, Thomson A . Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012; 18(42):6036-59. PMC: 3496881. DOI: 10.3748/wjg.v18.i42.6036. View

14.

Plaza-Izurieta L, Fernandez-Jimenez N, Irastorza I, Jauregi-Miguel A, Romero-Garmendia I, Vitoria J . Expression analysis in intestinal mucosa reveals complex relations among genes under the association peaks in celiac disease. Eur J Hum Genet. 2014; 23(8):1100-5. PMC: 4795102. DOI: 10.1038/ejhg.2014.244. View

15.

Tagkalidis P, Gibson P, Bhathal P . Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol. 2006; 60(4):382-7. PMC: 2001106. DOI: 10.1136/jcp.2005.036376. View

16.

Granzotto M, Dal Bo S, Quaglia S, Tommasini A, Piscianz E, Valencic E . Regulatory T-cell function is impaired in celiac disease. Dig Dis Sci. 2008; 54(7):1513-9. DOI: 10.1007/s10620-008-0501-x. View

17.

Safari-Alighiarloo N, Taghizadeh M, Tabatabaei S, Namaki S, Rezaei-Tavirani M . Identification of common key genes and pathways between type 1 diabetes and multiple sclerosis using transcriptome and interactome analysis. Endocrine. 2020; 68(1):81-92. DOI: 10.1007/s12020-019-02181-8. View

18.

Troncone R, Gianfrani C, Mazzarella G, Greco L, Guardiola J, Auricchio S . Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4. Dig Dis Sci. 1998; 43(1):156-61. DOI: 10.1023/a:1018896625699. View

19.

Mansouri V, Rezaei-Tavirani M, Zadeh-Esmaeel M, Rezaei-Tavirani S, Razzaghi M, Okhovatian F . Analysis of Laser Therapy Effects on Squamous Cell Carcinoma Patients: A System Biology Study. J Lasers Med Sci. 2020; 10(Suppl 1):S1-S6. PMC: 6983861. DOI: 10.15171/jlms.2019.S1. View

20.

Liu M, Liberzon A, Kong S, Lai W, Park P, Kohane I . Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet. 2007; 3(6):e96. PMC: 1904360. DOI: 10.1371/journal.pgen.0030096. View